EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

REG3A: A Potential Fecal Biomarker for Ulcerative Colitis

Xinrui Lv iD, Yaxin Qi iD, Jia Guo iD, Ling Ba iD, Sipu Wang iD, Hailong Cao iD, Xin Xu iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/9316792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 25.06.2026. Verfasst von Xinrui Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China, tjmugh.com.cn. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Pancreatitis-Associated Proteins, Feces, Biomarkers. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qingfeng Scientific Research Fund of the China Crohn's & Colitis Foundation (CCCF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regenerating islet‐derived protein 3‐alpha (REG3A), a member of the regenerating islet‐derived protein (Reg) family, belongs to the C‐type lectin class of antimicrobial peptides (AMPs). It has been recognized as a critical component of intestinal mucosal barrier damage and repair. In a prospective cohort (82 ulcerative colitis [UC] patients, 20 controls), UC patients were stratified by clinical partial Mayo Score (pMS) and endoscopic activity. Fecal REG3A levels were measured across distinct patient cohorts, and diagnostic performance was evaluated and compared against fecal calprotectin (FC) and a combined model using receiver operating characteristic (ROC) analysis. REG3A expression was also evaluated in intestinal biopsies via immunohistochemistry. Fecal REG3A levels increased stepwise with UC clinical severity ( p < 0.001), peaking in the severe activity group. A combined model of REG3A and FC outperformed either biomarker alone in differentiating disease activity, achieving the highest area under the curves (AUCs) for distinguishing remission from mild activity and mild from moderate activity. Immunohistochemistry confirmed REG3A expression in active UC colonic tissues. Our results indicate that fecal REG3A serves as a promising biomarker for assessing disease activity in UC. Its combination with FC enhances the accuracy of predicting clinical severity in UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativePancreatitis-Associated ProteinsFecesBiomarkersHumansMaleFemaleLeukocyte L1 Antigen ComplexImmunohistochemistryAdultMiddle AgedProspective StudiesROC Curve

Stichwörter der Autor:innen

fecal calprotectinregenerating islet-derived protein 3-alphaulcerative colitis

Substanzen

Pancreatitis-Associated ProteinsBiomarkersREG3A protein, humanLeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China, tjmugh.com.cn.

ORCID-Profile: Xinrui Lv, Yaxin Qi, Jia Guo, Ling Ba, Sipu Wang, Hailong Cao, Xin Xu

Förderung

  • Qingfeng Scientific Research Fund of the China Crohn's & Colitis Foundation (CCCF)

Zitieren

APA

Lv, X., Qi, Y., Guo, J., Ba, L., Wang, S., Cao, H., & Xu, X. (2026). REG3A: A Potential Fecal Biomarker for Ulcerative Colitis. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/9316792

Vancouver

Lv X, Qi Y, Guo J, Ba L, Wang S, Cao H, et al. REG3A: A Potential Fecal Biomarker for Ulcerative Colitis. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/9316792

BibTeX
@article{Lv2026,
  author = {Lv, Xinrui and Qi, Yaxin and Guo, Jia and Ba, Ling and Wang, Sipu and Cao, Hailong and Xu, Xin},
  title = {REG3A: A Potential Fecal Biomarker for Ulcerative Colitis},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/9316792}
}
Kostenlos starten →